- Home
- SYBX vs EKSO Comparison
SYBX vs EKSO Comparison
Compare SYBX & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- EKSO
- Stock Information
- Founded
- SYBX N/A
- EKSO 2005
- Country
- SYBX United States
- EKSO United States
- Employees
- SYBX N/A
- EKSO N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- SYBX Health Care
- EKSO Health Care
- Exchange
- SYBX Nasdaq
- EKSO Nasdaq
- Market Cap
- SYBX 13.6M
- EKSO 13.6M
- IPO Year
- SYBX N/A
- EKSO N/A
- Fundamental
- Price
- SYBX $1.11
- EKSO $0.42
- Analyst Decision
- SYBX
- EKSO Strong Buy
- Analyst Count
- SYBX 0
- EKSO 2
- Target Price
- SYBX N/A
- EKSO $2.50
- AVG Volume (30 Days)
- SYBX 11.1K
- EKSO 204.6K
- Earning Date
- SYBX 05-20-2025
- EKSO 05-05-2025
- Dividend Yield
- SYBX N/A
- EKSO N/A
- EPS Growth
- SYBX N/A
- EKSO N/A
- EPS
- SYBX 0.21
- EKSO N/A
- Revenue
- SYBX N/A
- EKSO $17,544,000.00
- Revenue This Year
- SYBX N/A
- EKSO $0.20
- Revenue Next Year
- SYBX N/A
- EKSO $42.29
- P/E Ratio
- SYBX $5.25
- EKSO N/A
- Revenue Growth
- SYBX N/A
- EKSO N/A
- 52 Week Low
- SYBX $0.90
- EKSO $0.34
- 52 Week High
- SYBX $1.91
- EKSO $1.53
- Technical
- Relative Strength Index (RSI)
- SYBX 45.73
- EKSO 66.62
- Support Level
- SYBX $1.00
- EKSO $0.42
- Resistance Level
- SYBX $1.19
- EKSO $0.53
- Average True Range (ATR)
- SYBX 0.09
- EKSO 0.06
- MACD
- SYBX 0.00
- EKSO 0.00
- Stochastic Oscillator
- SYBX 55.00
- EKSO 57.72
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.